Skip to main content
. 2020 Sep 15;9(21):8004–8019. doi: 10.1002/cam4.3434

FIGURE 2.

FIGURE 2

Hepatocellular carcinoma (HCC) patient diagnostic trial by using MAOA as a marker. A, The summary receiver operating characteristic (sROC) curve exhibited a marvelous discriminatory capacity of MAOA in HCC and non‐HCC patients. B, Fagan's nomogram, (C) diagnostic likelihood ratio negative (DLR N), and (D) diagnostic likelihood ratio positive (DLR N) also addressed the diagnostic value of MAOA for HCC patients